ARTICLE | Financial News
NightstaRx completes venture financing
November 16, 2015 8:00 AM UTC
NightstaRx Ltd., London, U.K. Business: Gene/Cell therapy, Ophthalmic Date completed: 2015-11-09 Type: Venture financing Raised: $35 million Investors: New Enterprise Associates; Syncona Partners LLP ...